ClinicalTrials.gov
ClinicalTrials.gov Menu

An Open Label Treatment Protocol to Provide Continued Elvucitabine Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00675844
Recruitment Status : Completed
First Posted : May 12, 2008
Last Update Posted : February 13, 2014
Sponsor:
Collaborators:
Bellos, Nicholaos C., M.D.
Central Texas Primary Care Research Network
Orlando Immunology Center
Saint Michael
Center for the Prevention and Treatment of Infections
Information provided by:
Achillion Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2010
  Actual Study Completion Date : March 2010
  Certification/Extension First Submitted : January 20, 2014